Centers for Disease Control and Prevention. Cerebral Palsy. https://www.cdc.gov/ncbddd/cp/index.html.
Vitrikas, K., Dalton, H. & Breish, D. Cerebral Palsy: An Overview. Am. Fam. Physician 101, 213–220 (2020).
McIntyre, S. et al. Global prevalence of cerebral palsy: A systematic analysis. Dev. Med. Child Neurol. 64, 1494–1506 (2022).
Article PubMed PubMed Central Google Scholar
O’Shea, T. M. Diagnosis, treatment, and prevention of cerebral palsy. Clin. Obstet. Gynecol. 51, 816–828 (2008).
Article PubMed PubMed Central Google Scholar
Patel, D. R., Neelakantan, M., Pandher, K. & Merrick, J. Cerebral palsy in children: a clinical overview. Transl. Pediatr. 9, S125–s135 (2020).
Article PubMed PubMed Central Google Scholar
Richards, C. L. & Malouin, F. Cerebral palsy: definition, assessment and rehabilitation. Handb. Clin. Neurol. 111, 183–195 (2013).
Musselman, K. E. et al. Prevalence of ataxia in children: a systematic review. Neurology 82, 80–89 (2014).
Article PubMed PubMed Central Google Scholar
Delgado, M. R. et al. Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study. Dev. Med Child Neurol. 63, 592–600 (2021).
Dursun, N. et al. Efficacy of Repeat AbobotulinumtoxinA (Dysport®) Injections in Improving Gait in Children with Spastic Cerebral Palsy. Dev. Neurorehabil 23, 368–374 (2020).
Multani, I., Manji, J., Hastings-Ison, T., Khot, A. & Graham, K. Botulinum Toxin in the Management of Children with Cerebral Palsy. Paediatr. Drugs 21, 261–281 (2019).
Article PubMed PubMed Central Google Scholar
Strobl, W. et al. Best clinical practice in botulinum toxin treatment for children with cerebral palsy. Toxins (Basel) 7, 1629–1648 (2015).
Article CAS PubMed Google Scholar
Whelan, M. A. & Delgado, M. R. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology and the practice committee of the child neurology society. Neurology 75, 669 (2010).
Novak, I. et al. State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy. Curr. Neurol. Neurosci. Rep. 20, 3 (2020).
Article PubMed PubMed Central Google Scholar
Bohn, E., Goren, K., Switzer, L., Falck-Ytter, Y. & Fehlings, D. Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis. Dev. Med Child Neurol. 63, 1038–1050 (2021).
Article PubMed PubMed Central Google Scholar
Hägglund, G. et al. Treatment of spasticity in children and adolescents with cerebral palsy in Northern Europe: a CP-North registry study. BMC Neurol. 21, 276–276 (2021).
Article PubMed PubMed Central Google Scholar
Goyal, V., Laisram, N., Wadhwa, R. K. & Kothari, S. Y. Prospective Randomized Study of Oral Diazepam and Baclofen on Spasticity in Cerebral Palsy. J. Clin. Diagn. Res 10, RC01–RC05 (2016).
CAS PubMed PubMed Central Google Scholar
Yadav, S., Chand, S., Majumdar, R. & Sud, A. Effect of botulinum toxin type-A in spasticity and functional outcome of upper limbs in cerebral palsy. J. Clin. Orthop. Trauma 11, 208–212 (2020).
Article PubMed PubMed Central Google Scholar
Flemban, A. & Elsayed, W. Effect of combined rehabilitation program with botulinum toxin type A injections on gross motor function scores in children with spastic cerebral palsy. J. Phys. Ther. Sci. 30, 902–905 (2018).
Article PubMed PubMed Central Google Scholar
Stray, L. L., Stray, T., Iversen, S., Ruud, A. & Ellertsen, B. Methylphenidate improves motor functions in children diagnosed with Hyperkinetic Disorder. Behav. Brain Funct. 5, 21 (2009).
Article PubMed PubMed Central Google Scholar
Jacobi-Polishook, T., Shorer, Z. & Melzer, I. The effect of methylphenidate on postural stability under single and dual task conditions in children with attention deficit hyperactivity disorder - a double blind randomized control trial. J. Neurol. Sci. 280, 15–21 (2009).
Article CAS PubMed Google Scholar
Boogerd, W. & Beijnen, J. H. Methylphenidate for cerebral palsy with choreoathetosis. Ann. Intern Med 132, 510 (2000).
Article CAS PubMed Google Scholar
Gladstone, D. J. et al. Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 37, 179–185 (2006).
Grade, C., Redford, B., Chrostowski, J., Toussaint, L. & Blackwell, B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch. Phys. Med Rehabil. 79, 1047–1050 (1998).
Article CAS PubMed Google Scholar
Carucci, S. et al. Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis. Neurosci. Biobehav Rev. 120, 509–525 (2021).
Article CAS PubMed Google Scholar
Goldman, R. D. ADHD stimulants and their effect on height in children. Can. Fam. Physician 56, 145–146 (2010).
PubMed PubMed Central Google Scholar
Nyberg, F. Structural plasticity of the brain to psychostimulant use. Neuropharmacology 87, 115–124 (2014).
Article CAS PubMed Google Scholar
Reid, L. B., Rose, S. E. & Boyd, R. N. Rehabilitation and neuroplasticity in children with unilateral cerebral palsy. Nat. Rev. Neurol. 11, 390–400 (2015).
Matusz, P. J. et al. Somatosensory Plasticity in Pediatric Cerebral Palsy following Constraint-Induced Movement Therapy. Neural Plasticity 2018, 1891978 (2018).
Article PubMed PubMed Central Google Scholar
Ostry, D. J. & Gribble, P. L. Sensory Plasticity in Human Motor Learning. Trends Neurosci. 39, 114–123 (2016).
Article CAS PubMed PubMed Central Google Scholar
Levac, D., Colquhoun, H. & O’Brien, K. K. Scoping studies: advancing the methodology. Implement Sci. 5, 69 (2010).
Article PubMed PubMed Central Google Scholar
Arksey, H. & O’Malley, L. Scoping studies: towards a methodological framework. Int. J. Soc. Res. Methodol. 8, 19–32 (2005).
Tricco, A. C. et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann. Intern Med 169, 467–473 (2018).
Gronseth G. S., et al. Clinical Practice Guideline Process Manual. Am. Acad. Neurol. (2017).
Hurst, D. L. & Lajara-Nanson, W. Use of modafinil in spastic cerebral palsy. J. Child Neurol. 17, 169–172 (2002).
Hurst, D. L., Lajara-Nanson, W. A., Dinakar, P. & Schiffer, R. B. Retrospective review of modafinil use for cerebral palsy. J. Child Neurol. 19, 948–951 (2004).
Hurst, D. L., Lajara-Nanson, W. A. & Lance-Fish, M. E. Walking with modafinil and its use in diplegic cerebral palsy: retrospective review. J. Child Neurol. 21, 294–297 (2006).
Murphy, A. M., Milo-Manson, G., Best, A., Campbell, K. A. & Fehlings, D. Impact of modafinil on spasticity reduction and quality of life in children with CP. Dev. Med Child Neurol. 50, 510–514 (2008).
Sadowska, M., Sarecka-Hujar, B. & Kopyta, I. Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatr. Dis. Treat. 16, 1505–1518 (2020).
Article PubMed PubMed Central Google Scholar
Volkow, N. D. et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. Jama 301, 1148–1154 (2009).
Article CAS PubMed PubMed Central Google Scholar
Schmidt, A. et al. Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects. Int J. Neuropsychopharmacol. 20, 712–720 (2017).
Article CAS PubMed PubMed Central Google Scholar
Lange, R., Volkmer, M., Heesen, C. & Liepert, J. Modafinil effects in multiple sclerosis patients with fatigue. J. Neu
Comments (0)